Search research articles
Contact Us
Filters
Showing results (241-250 of 290) with videos related to
Page
of 29
Sort By:
Science (New York, N.Y.)
|
April 15, 2000
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
M Li, V O Ona, C Guégan, et al.
Haematologica
|
November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma
Adam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology
M J Ryan, F A Bjork, D M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor
M J Ryan, D M Boucher, D M Cohen, et al.
Journal of Oncology Practice
|
February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program
Kalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.
Journal of Geriatric Oncology
|
April 27, 2024
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study
Courtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.
Cancers
|
March 28, 2025
Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based Study
Courtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.
Cancer Biology & Therapy
|
July 11, 2022
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma
Andrew Hsu, Kelsey E Huntington, Andre De Souza, et al.
Cancer
|
July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies
Thomas A Ollila, Rebecca H Masel, John L Reagan, et al.
Experimental Hematology & Oncology
|
May 14, 2025
Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study
Narendranath Epperla, Geoffrey Shouse, Natalie S Grover, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 290) with videos related to
Sort By:
Page
of 29
Science (New York, N.Y.)
|
April 15, 2000
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
M Li, V O Ona, C Guégan, et al.
Haematologica
|
November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma
Adam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology
M J Ryan, F A Bjork, D M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor
M J Ryan, D M Boucher, D M Cohen, et al.
Journal of Oncology Practice
|
February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program
Kalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.
Journal of Geriatric Oncology
|
April 27, 2024
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study
Courtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.
Cancers
|
March 28, 2025
Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based Study
Courtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.
Cancer Biology & Therapy
|
July 11, 2022
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma
Andrew Hsu, Kelsey E Huntington, Andre De Souza, et al.
Cancer
|
July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies
Thomas A Ollila, Rebecca H Masel, John L Reagan, et al.
Experimental Hematology & Oncology
|
May 14, 2025
Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study
Narendranath Epperla, Geoffrey Shouse, Natalie S Grover, et al.
Page
of 29